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Abstract
Background: Statistical methods for ranking differentially expressed genes (DEGs) from gene expression data
should be evaluated with regard to high sensitivity, specificity, and reproducibility. In our previous studies, we
evaluated eight gene ranking methods applied to only Affymetrix GeneChip data. A more general evaluation that
also includes other microarray platforms, such as the Agilent or Illumina systems, is desirable for determining which
methods are suitable for each platform and which method has better inter-platform reproducibility.
Results: We compared the eight gene ranking methods using the MicroArray Quality Control (MAQC) datasets
produced by five manufacturers: Affymetrix, Applied Biosystems, Agilent, GE Healthcare, and Illumina. The area under
the curve (AUC) was used as a measure for both sensitivity and specificity. Although the highest AUC values can vary
with the definition of “true” DEGs, the best methods were, in most cases, either the weighted average difference
(WAD), rank products (RP), or intensity-based moderated t statistic (ibmT). The percentages of overlapping genes
(POGs) across different test sites were mainly evaluated as a measure for both intra- and inter-platform
reproducibility. The POG values for WAD were the highest overall, irrespective of the choice of microarray platform.
The high intra- and inter-platform reproducibility of WAD was also observed at a higher biological function level.
Conclusion: These results for the five microarray platforms were consistent with our previous ones based on 36
real experimental datasets measured using the Affymetrix platform. Thus, recommendations made using the MAQC
benchmark data might be universally applicable.
Background
Identification of differentially expressed genes (DEGs)
under different conditions is an important goal in
microarray-based gene expression analysis. For this
identification, new gene ranking methods have been
developed and comparative studies have been performed
[1-8]. Several evaluation metrics for comparing these
methods have also been used [8-17]. A major metric is
the area under the curve (AUC), which evaluates both
sensitivity and specificity of the methods simultaneously
[8,14-17]. A high AUC value indicates that a set of true
DEGs are highly concentrated at the top in ranked gene
lists.
Currently, by virtue of the MicroArray Quality Control
(MAQC) project [18,19], researchers can comprehen-
sively evaluate many competing methods with regard to
reproducibility, another important metric [9-14]. The
MAQC study provides a large number of benchmark
datasets measured using different microarray platforms
and at different test sites for a set of common samples
(so-called “Samples A-D"; for details, see Materials and
Methods). This enables us to evaluate inter-site (or intra-
platform) and inter-platform reproducibility. The study
concluded that a fold-change-based method, an average
difference (AD) statistic for log-scale data, has the most
reproducible results of ranked gene lists when inter-site
reproducibility for the DEG lists was evaluated [18].
However, many other existing methods, such as rank
products (RP) [4], were not compared in the original
study. Moreover, new methods such as weighted average
difference (WAD) [8] have been developed since the
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MAQC study. Evaluations for those methods are there-
fore important for creating up-to-date guidelines.
We recently reported that WAD outperformed AD,
which was recommended by the MAQC study with
regard to inter-site reproducibility. We also reported that
the use of WAD or RP, in conjunction with suitable pre-
processing algorithms dedicated to the Affymetrix (AFX)
GeneChip data, can increase both sensitivity and specifi-
city of the results [14]. However, as the datasets we used
were derived from only one platform (i.e., the AFX data),
the applicability of the conclusions to other platforms,
such as Agilent One-Color (AG1) and Applied Biosys-
tems (ABI) data, should be determined.
In this study, we analyzed the MAQC data [18,19] mea-
sured using five platforms: ABI, AG1, GE Healthcare
(GEH), and Illumina (ILM), as well as AFX. We report
the suitable gene ranking methods having high sensitivity,
specificity, and inter-site and inter-platform reproducibil-
ity for these data. We also report the capability of the
recommended methods for generating consistent results
at higher biological function levels as well as lower DEG
list levels. Our recommendations for the five platforms
are essentially the same as the previous ones, which were
based on 36 real experimental datasets measured using
only the AFX platform [14].
Methods
MAQC expression data
Expression data derived from five platforms, i.e., AFX,
ABI, AG1, GEH, and ILM, were obtained from the
MAQC website [20] and analyzed. The MAQC project
produced four sample types: Sample A, a universal
human reference RNA; Sample B, a human brain refer-
ence RNA; Sample C, consisting of 75 and 25 % Samples
A and B respectively; and Sample D, consisting of 25 and
75% Samples A and B respectively [18]. Five replicate
experiments for each of the four sample types at three
(for ABI, AG1, GEH, and ILM) and six (for AFX) test
sites were conducted. The downloaded data were pre-
processed using the individual manufacturer protocols.
More detail about pre-processing is given in Ref. [18].
The gene ranking methods were independently applied
for “Sample A versus B” and “Sample C versus D”
comparisons.
For the GEH data, signals from multiple probes with
the same ID (e.g., 12 probes with the ID “GE1071362”
were present) were averaged. This produced 53,517
unique probes from the original 54,359 probes. Then,
signals under a minimum value for signals flagged as
‘Good’ quality were set to the minimum value (i.e.,
0.169). This substitution of a floor value was made for
21.75% (698,424/(53,517 probes × 60 samples)) of the
signals. For reproducing the research, the R-code for the
preprocessing of GEH data is available in Additional
file 1. After the preprocessing of the GEH data, log2
transformation was performed. The GEH data, i.e.,
53,517 probes, were used for analyzing sensitivity and
specificity. For the other platforms (ABI, AFX, AG1, and
ILM), the expression data on a log2 scale were analyzed.
MAQC RT-PCR data
Quantitative real-time polymerase chain reaction (RT-
PCR) data were obtained from the MAQC website [20]
and used for defining “true” DEGs. The original MAQC
study [19] produced TaqMan (TAQ) assay data on 997
genes, StaRT-PCR (GEX) assay data on 205 genes, and
QuantiGene (QGN) assay data on 244 genes. Of these,
we only used the TAQ assay data on 905 genes and the
GEX assay data on 161 genes because those genes were
common among the five different microarray platforms.
To determine the DEGs, we applied two metrics for the
log2 transformed data: a t-test and an AD statistic (i.e.,
log-fold-change). The false discovery rate (FDR) for the p-
values from the t-test was calculated using the Benjamini
and Hochberg approach [21]. DEGs were selected based
on FDR < 0.05 or an absolute AD value > 1. For compar-
ing “Sample A versus B” using the TAQ data, the FDR
threshold defined 817 genes as DEGs (TAQ_AB_FDR =
817, denoted as “Platform_Comparison_Metric “) and the
AD threshold produced 553 DEGs (TAQ_AB_AD = 553).
Similarly, 767, 351, 144, 106, 114, and 60 DEGs were
determined by TAQ_CD_FDR, TAQ_CD_AD, GEX_-
AB_FDR, GEX_AB_AD, GEX_CD_FDR, and GEX_C-
D_AD, respectively. The R-codes for analyzing the TAQ
and GEX data are available in Additional files 2 and 3,
respectively.
Gene ranking
The genes were ranked according to the differential
expression using R (ver. 2.11.0) [22] and Bioconductor
[23]. Following on from our previous study [8,14], eight
methods for analyzing two-class data were compared: the
WAD [8], AD [8], fold change (FC), RP [4], moderated t
statistic (modT) [3], significance analysis of microarrays
(samT) [1], shrinkage t statistic (shrT) [7], and intensity-
based moderated t statistic (ibmT) [6]. A higher absolute
value for all methods except for RP indicates a higher
degree of differential expression. The genes were ranked
in descending order of the absolute value.
RP is only a rank-based non-parametric method. Differ-
ent from the other methods, RP independently handles
up-regulated genes and down-regulated genes under one
class and therefore produces two separate ranked gene
lists. In other words, RP outputs two values per gene. To
obtain one RP value per gene for comparison with the
results of the other methods, we defined a lower value as a
net value for the gene. A small net value for RP is there-
fore evidence of differential expression. This procedure is
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the same as that described in Ref. [14]. The genes were
ranked in ascending order of the net value.
For evaluation of the methods based both on sensitiv-
ity and specificity, an AUC value was calculated for each
ranked gene list, where true DEGs were mainly defined
by two metrics (i.e., FDR and AD) as mentioned above.
For evaluation based on inter-site and inter-platform
reproducibility, the percentages of overlapping genes
(POGs) and Spearman’s rank correlation coefficients
between different ranked gene lists were calculated.
Functional analysis
Analyzing gene set enrichment is a common approach
in functional analysis where functionally or structurally
related sets of genes regarding differential expression are
assessed. Methods for this purpose include Gene Set
Enrichment Analysis (GSEA) [24] and Parametric Analy-
sis of Gene Set Enrichment (PAGE) [25]. These methods
calculate the differences between two classes of samples
(e.g., Sample A versus B) by using associative statistics,
such as a signal-to-noise metric [24] or AD [25], and
output one score per gene set. Different associative sta-
tistics with a particular method (e.g., GSEA with AD
and GSEA with samT) could result in different top-rank
lists of gene sets.
To compare the performances of the eight gene rank-
ing methods as simply as possible, we calculate the aver-
age of the ranks of the genes belonging to a gene set as
an “enrichment score”. Consider a gene ranking method
that produces m associative statistics S = {s1, s2, ..., sm}
composed of m genes. Given R = {r1, r2, ..., rm} as the cor-
responding ranks of the values of the statistics and G =
{g1, g 2, ..., gn} as a gene set composed of n genes, the





i∈G ri. For example, consider three genes
in a gene set ranked as 2nd, 8th, and 14th respectively. The
enrichment score is simply calculated as EG= (2+8+14)/3
= 8. Accordingly, if a gene set has a small EGvalue, it is
expected to be enriched (or de-regulated) in the two
classes analyzed.
The gene sets were obtained from the Molecular Sig-
natures Databases (MSigDB) ver. 3.0 [24]. We used 186
gene sets associated with the Kyoto Encyclopedia of
Genes and Genomes (KEGG) Pathway. Since the analy-
sis of gene set enrichment provides an enrichment score
for each gene set, we obtained 186 enrichment scores
for each gene ranking method. The pathways were ana-
lyzed for each of the eight gene ranking methods, each
of the two comparisons ("Sample A versus B” and “C
versus D”), each of the three test sites, and each of the
five microarray platforms. Accordingly, the analysis pro-
duced a total of (8 × 2 × 3 × 5 =) 240 lists, each of
which had 186 scores. Since the comparisons were
performed for each platform, each list was denoted as
“Method_Comparison_Site “.
Gene set information is available as gene symbols,
while expression data are measured on the probe basis.
Inevitably, many multiple probes are mapped to the same
gene on existing microarray platforms. For example,
three probes (’201127_s_at’, ‘201128_s_at’, and
‘210337_s_at’) are mapped to the ACLY gene on the AFX
platform, while only one probe is mapped to that gene
on the other platforms (’102218’ for ABI, ‘17711’ for
AG1, ‘199102’ for GEH, and ‘GI_38569420-S’ for ILM).
In this case, expression signals for the three probes on
the AFX platform should be collapsed to avoid inflating
the enrichment scores and to facilitate biological inter-
pretation of the analysis results [24]. We averaged the
signals from the probes mapped to the same gene.
The mapping information for the five platforms was
obtained from the Gene Expression Omnibus [26] as
‘GPL570’ for AFX, ‘GPL2986’ for ABI, ‘GPL1708’ for AG1,
‘GPL2895’ for GEH, and ‘GPL2507’ for ILM. For the GEH
data, the original data composed of 54,359 probes were
collapsed. After this, expression data composed of 20,723
unique genes for AFX, 16,275 for ABI, 19,053 for AG1,
19,352 for GEH, and 16,992 for ILM on a log2 scale were
analyzed. The POGs and Spearman’s rank correlation
coefficients for the 186 enrichment scores between test
sites (or different platforms) were calculated for estimating
inter-site (or inter-platform) reproducibility of the indivi-
dual gene ranking methods at the function level.
Results
Investigation of suitable gene ranking methods having high
sensitivity, specificity, and (inter-site and inter-platform)
reproducibility is the main purpose of this work. Similar to
our previous study on the AFX platform [14], eight gene
ranking methods (WAD, AD, FC, RP, modT, samT, shrT,
and ibmT) were evaluated. Compared to the abundant real
experimental data measured using the AFX platform in
our previous study, the data for other platforms are consid-
erably limited. We therefore analyzed the MAQC data
measured using five platforms (AFX, ABI, AG1, GEH, and
ILM). The results for the MAQC AFX data were compared
with our previous results, where 36 real experimental data-
sets measured using the AFX platform were analyzed [14].
We will follow the terminology used in our previous study
[14] for consistency.
Sensitivity and specificity
We and other researchers believe the human samples
compared in the MAQC study, cell lines (sample A) ver-
sus brain tissues (sample B), are clearly distinct, i.e.,
such comparisons are unrealistic in practical biological
research [27-29]. This may weaken the confidence of
any results obtained using the MAQC benchmark data.
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To mitigate this concern, we first analyzed the MAQC
data measured using the AFX platform and compared
the current results to our previous ones (where the best
method was either WAD or RP) [14]. The evaluation
frameworks were set to be as similar as possible to
those in the previous study [14]. Two assay technologies
for RT-PCR data (TAQ and GEX) [19] were used to
determine true DEGs, and an AUC value was used to
compare sensitivity and specificity simultaneously
[30-32]. Currently, there is no convincing rationale for
defining DEGs from the RT-PCR data. We here define
DEGs by two metrics: a FDR threshold (FDR < 0.05)
and an absolute AD threshold (|AD| > 1; AD corre-
sponds to “log-fold-change”).
The average AUC values for the AFX data across six
test sites are shown in Table 1. WAD and RP, recom-
mended by Ref. [14], show the best performance in six of
the eight cases. Note that the ibmT method also shows
high AUC values as a whole; it is always the second best
when WAD is the best. These observations are similar to
those in our previous study [14], suggesting that findings
derived from the MAQC data measured using the other
four platforms (ABI, AG1, GEH, and ILM) could be
applicable for practical microarray research.
The average AUC values for ABI, AG1, GEH, and
ILM data across three test sites are shown in Table 2.
Similar to the results for the AFX data, the best was
either WAD, RP, or ibmT in all but one (i.e., TAQ_A-
B_AD ) case. The ibmT method may be suitable for ABI
data. RP was overall good when DEGs were determined
by the AD metric for TAQ RT-PCR data. WAD was
overall good when DEGs were determined by the FDR
metric from a t-test, regardless of the choice of RT-PCR
technology (i.e., TAQ or GEX).
Note that these results were based on only two sets of
DEGs arbitrarily defined by commonly used procedures
(i.e., FDR < 0.05 and |AD| > 1). As the AUC values vary
with the thresholds for individual metrics, the effects of
changing the parameters should also be analyzed. Table
3 shows the gene ranking methods having the highest
AUC values when the top X genes are defined as DEGs
(X = 100, 200, 300, ..., and 800 for TAQ data and 50,
100, and 150 for GEX data). We confirmed the super-
iority of the WAD, RP, and ibmT methods against var-
ious thresholds.
For reproducing the research, the R-codes for obtain-
ing the AUC values shown in Tables 1 and 2 are given
in Additional files 4, 5, 6, 7 and 8. The raw AUC values
for all methods shown in Table 3 and the R-code for
obtaining a fraction of the values are given in Additional
files 9 and 10, respectively.
Inter-site reproducibility at lower DEG list level
Next, we examined the inter-site reproducibility of
ranked gene lists among three test sites for each plat-
form. Our previous study using AFX data reports that
WAD is the most reproducible method when POG is
evaluated (Figure one in Ref. [14]). The POG values for
the 100 top-ranked genes among three test sites for the
five platforms AFX, ABI, AG1, GEH, and ILM are
shown in Table 4. The complete POG values are given
in Additional files 11 and 12.
The POG values for WAD were clearly higher than
those for the other seven methods, especially in the
“Sample C versus D” comparison. The results of that
comparison should take precedence over those of “Sam-
ple A versus B”. This is because sample C is a 3:1 and
sample D is a 1:3 mixture of samples A and B, respec-
tively, and real biological samples consist of various
kinds of tissues and cells. These results suggest that the
use of WAD can be promising for users concerned
about inter-site reproducibility at the DEG list level.
Note that the POG values shown in Table 4 only
describe inter-site (or intra-platform) reproducibility
Table 1 Average AUC values for AFX data
Technology TAQ TAQ TAQ TAQ GEX GEX GEX GEX
Comparison AB AB CD CD AB AB CD CD
Metric FDR AD FDR AD FDR AD FDR AD
#DEGs 817 553 767 351 144 106 114 60
WAD 69.91 75.74 71.41 77.69 75.74 78.75 76.54 80.69
AD 67.73 77.45 69.19 81.24 70.77 76.60 71.26 78.96
FC 67.73 77.44 69.17 81.20 70.79 76.61 71.35 78.95
RP 67.37 77.43 68.85 81.78 70.61 76.36 71.19 79.46
modT 68.74 76.98 70.19 79.95 73.12 77.67 73.53 80.77
samT 67.96 77.52 69.49 81.05 71.26 76.87 71.93 79.61
shrT 68.64 77.11 70.16 80.08 72.90 77.64 73.39 80.68
ibmT 69.26 76.85 70.70 79.57 74.27 78.26 74.87 81.33
Average AUC values across six test sites. Highest AUC values for each case are in bold. A total of 8 cases (2 assay technologies × 2 comparisons × 2 metrics) are
shown. For example, AUC value for samT (77.52) was the highest in TAQ_AB_AD case, where 553 genes were defined as DEGs.
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among three test sites for each gene ranking method.
Accordingly, there may be concern about the potential
difference of the ranked gene lists between WAD and
the other methods. Figure 1 shows the results of hier-
archical clustering applied to a total of 48 ranked gene
lists (8 methods × 2 comparisons × 3 test sites = 48
lists; each list is therefore denoted as “Method_Compari-
son_Site “). Each list consists of (a) 54,676 gene ranks
for AFX data, (b) 32,879 for ABI, (c) 41,059 for AG1,
(d) 53,517 for GEH, and (e) 47,294 for ILM. When we
focus on the dendrograms for the ILM data (Figure 1e),
six distinct clusters can be seen, each consisting of eight
lists with the same sample comparison and the same
test site but different gene ranking methods. We also
observe this trend for the ABI data (Figure 1b). Different
from those for the ILM and ABI data, the dendrogram
for the AG1 data shows a distinct WAD cluster (Figure
1c). This cluster is clearly located in a larger cluster
mainly consisting of gene lists from the “Sample A ver-
sus B” comparison. These results indicate that the
Table 2 Average AUC values for ABI, AG1, GEH, and ILM data
Technology TAQ TAQ TAQ TAQ GEX GEX GEX GEX
Comparison AB AB CD CD AB AB CD CD
Metric FDR AD FDR AD FDR AD FDR AD
#DEGs 817 553 767 351 144 106 114 60
ABI
WAD 66.18 74.77 67.30 77.46 70.71 74.49 70.01 76.62
AD 63.45 75.49 62.88 78.92 65.33 71.14 61.86 71.10
FC 62.93 75.00 62.27 78.63 64.95 70.76 60.84 70.42
RP 62.46 75.45 60.28 79.58 64.17 70.43 58.37 68.82
modT 66.03 73.63 67.62 76.75 71.27 74.84 70.54 77.31
samT 64.00 75.63 63.80 79.23 66.36 71.92 63.34 72.57
shrT 65.60 74.91 66.86 78.05 69.75 74.12 68.80 76.54
ibmT 66.37 73.43 67.93 76.41 71.99 75.26 71.12 77.39
AG1
WAD 66.73 73.14 67.39 74.69 71.28 75.58 72.67 77.80
AD 64.60 75.20 64.41 78.48 65.73 73.53 65.75 75.65
FC 64.32 75.15 63.01 77.55 65.42 73.58 63.98 73.95
RP 64.37 75.20 65.03 79.35 65.38 72.78 66.45 76.02
modT 65.66 74.25 66.00 76.42 68.80 74.78 70.44 77.75
samT 64.26 74.29 64.77 78.66 66.34 73.79 66.49 76.24
shrT 65.47 74.78 65.67 77.76 68.01 74.65 69.19 77.89
ibmT 65.97 74.32 66.34 76.59 69.80 75.61 71.22 78.86
GEH
WAD 74.03 78.39 74.64 79.38 76.18 79.19 76.87 81.26
AD 71.27 78.60 71.24 80.36 70.50 75.64 70.09 77.28
FC 71.16 78.50 70.81 80.21 70.30 75.48 69.84 77.05
RP 71.19 78.68 70.97 80.62 70.58 75.71 69.93 77.54
modT 71.90 78.04 71.74 79.01 71.18 75.46 72.25 78.26
samT 71.40 78.66 71.54 80.48 70.61 75.69 70.72 77.76
shrT 72.02 78.64 72.12 80.13 71.30 75.89 72.19 78.63
ibmT 71.87 78.01 71.70 78.99 71.14 75.41 72.27 78.31
ILM
WAD 79.13 82.49 78.94 82.63 83.25 84.79 82.09 83.88
AD 77.43 83.85 76.33 84.64 79.92 83.71 77.93 82.93
FC 77.39 83.83 76.35 84.63 79.90 83.77 78.14 83.17
RP 77.58 84.23 76.10 85.28 79.81 83.94 77.97 84.13
modT 77.45 82.98 76.73 83.56 80.64 83.78 78.70 82.96
samT 77.42 83.63 76.53 84.39 80.08 83.70 78.28 83.02
shrT 77.39 83.05 76.72 83.58 80.49 83.73 78.64 82.93
ibmT 77.94 82.96 77.53 83.48 81.37 84.04 79.77 83.31
Average AUC values across three test sites. Reminder of legend is the same as in Table 1.
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ranked gene lists produced from WAD are undoubtedly
not outliers.
Similar to the POG values in Table 4 the inter-site
reproducibility can also be evaluated by calculating the
Spearman’s rank correlation coefficients of two ranked
gene lists. The high inter-site reproducibility of WAD
was also confirmed using this metric. The correlation
coefficients between any two test sites (i.e., “Site 1 ver-
sus 2”, “1 versus 3”, and “2 versus 3”) are given in Addi-
tional file 13.
Inter-site reproducibility at higher biological function
level
In general, the higher the reproducibility of a gene rank-
ing method at a lower DEG list level, the higher the
reproducibility the method should have at a higher bio-
logical function level. To clarify this idea, we performed
a functional analysis by estimating gene set enrichment.
There are many sophisticated methods for analyzing
gene set enrichment, such as GSEA [24] and PAGE
[25]. We calculated the average rank for genes belonging
to each gene set as the “enrichment score.” This was to
manipulate the eight gene ranking methods equally and
to perform the comparison as simply as possible (for
details, see Materials and Methods).
We performed the functional analysis for 186 gene
sets associated with KEGG Pathway. The POG values
for different settings of X top-ranked gene sets among
three test sites for the five platforms (AFX, ABI, AG1,
GEH, and ILM) are shown in Figure 2. While the best
methods depend on the number of top-ranked gene
sets, WAD seems to have relatively good performance
compared to the other methods. We also observed this
trend when Spearman’s rank correlation coefficients
were evaluated as another metric (see Additional
Table 3 List of best methods with different threshold settings for defining DEGs
Technology TAQ TAQ TAQ TAQ TAQ TAQ TAQ TAQ GEX GEX GEX
#DEGs 100 200 300 400 500 600 700 800 50 100 150
AFX
AB_FDR WAD WAD WAD WAD WAD WAD WAD WAD WAD WAD WAD
AB_AD RP AD AD RP RP samT ibmT WAD RP WAD WAD
CD_FDR AD RP WAD WAD WAD WAD WAD WAD WAD WAD WAD
CD_AD AD RP RP RP RP RP ibmT WAD ibmT WAD WAD
ABI
AB_FDR WAD ibmT WAD WAD WAD WAD WAD ibmT ibmT ibmT ibmT
AB_AD RP RP RP RP RP samT WAD ibmT samT ibmT ibmT
CD_FDR WAD WAD WAD WAD ibmT ibmT ibmT ibmT WAD ibmT ibmT
CD_AD RP RP RP samT shrT WAD ibmT ibmT ibmT ibmT ibmT
AG1
AB_FDR RP WAD WAD ibmT WAD WAD WAD WAD WAD WAD WAD
AB_AD RP RP RP RP RP RP ibmT WAD FC ibmT WAD
CD_FDR shrT WAD WAD WAD WAD WAD WAD WAD ibmT WAD WAD
CD_AD FC RP RP RP RP RP WAD WAD ibmT ibmT WAD
GEH
AB_FDR RP WAD WAD WAD WAD WAD WAD WAD WAD WAD WAD
AB_AD RP RP RP RP RP shrT WAD WAD WAD WAD WAD
CD_FDR WAD WAD WAD WAD WAD WAD WAD WAD WAD WAD WAD
CD_AD samT RP RP RP RP WAD WAD WAD WAD WAD WAD
ILM
AB_FDR AD WAD WAD WAD WAD WAD WAD WAD WAD WAD WAD
AB_AD RP RP RP RP RP RP RP WAD RP WAD WAD
CD_FDR RP RP WAD WAD WAD WAD WAD WAD WAD WAD WAD
CD_AD AD RP RP RP RP RP WAD WAD RP WAD WAD
Table 4 Inter-site reproducibility at lower DEG list level
Comparison AB AB AB AB AB CD CD CD CD CD
Platform AFX ABI AG1 GEH ILM AFX ABI AG1 GEH ILM
WAD 88 86 85 81 83 64 76 54 39 66
AD 76 76 73 81 85 23 11 2 5 18
FC 77 72 59 78 84 23 0 0 3 19
RP 78 72 76 79 78 20 8 2 7 9
modT 16 26 30 8 27 20 26 3 1 13
samT 71 63 42 73 45 32 31 5 10 21
shrT 17 33 43 23 28 21 40 2 1 12
ibmT 21 32 37 6 28 29 39 10 1 22
POG values for 100 top-ranked genes among three test sites. For AFX data,
POG values were calculated based on first three test sites.
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Figure 1 Dendrograms of average-linkage hierarchical clustering. Dendrograms for (a) AFX, (b) ABI, (c) AG1, (d) GEH, and (e) ILM data.
Spearman’s rank correlation coefficient is used as a similarity metric; left-hand scale represents (1- correlation coefficient). Each gene list is
denoted as “Method_Comparison_Site “. For example, a ranked list calculated from samT when comparing C versus D for site 2 data is denoted
as “samT_CD_2”.
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Figure 2 Inter-site reproducibility at higher biological function level. POG values for different settings of X top-ranked gene sets among
three test sites. For AFX data, POG values were calculated based on first three test sites.
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file 14). The raw data for Figure 2 are available in Addi-
tional file 15. The R-code for making the left side of
Figure 2(a) is also available in Additional file 16.
Inter-platform reproducibility at higher biological
function level
Note that the numbers of genes belonging to each gene set
differ across platforms. Only 5 of the 186 KEGG Pathway
gene sets (STEROID_BIOSYNTHESIS, VALINE_LEUCI-
NE_AND_ISOLEUCINE_BIOSYNTHESIS, FOLATE_BIO-
SYNTHESIS, TERPENOID_BACKBONE_BIOSYNTHESIS,
and RENIN_ANGIOTENSIN_SYSTEM ) were identical
across the 5 platforms. To estimate the overall similarity
among platforms, we calculated an intersection-union ratio
for each gene set. For example, there are 61, 61, 60, 54,
and 61 genes in the respective platforms AFX, ABI, AG1,
GEH, and ILM in the GLYCOLYSIS_GLUCONEOGEN-
ESIS pathway. As the intersection and union across the 5
platforms are 53 and 61, respectively, the ratio is 53/61 =
0.87. Detailed information on the 186 gene sets is available
in Additional file 17. The average of the 186 intersection-
union ratios was 0.83. Arguably, we assert this high value
enables a comparison between platforms.
The POG values for different settings of X top-ranked
gene sets among the five platforms are shown in Figure 3.
Similar to the results for inter-site reproducibility shown
X
Figure 3 Inter-platform reproducibility at higher biological function level. POG values for different settings of X top-ranked gene sets
among five platforms. Values correspond to intersections among five platforms shown in Figure 2 when comparing (a) A versus B and (b) C
versus D.
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in Figure 2, the results for inter-platform reproducibility
do not indicate the best gene ranking method because one
method does not always outperform the others, especially
when comparing ~25% of the top-ranked gene sets. This
result is somewhat disappointing because only ~20 top-
ranked gene sets have been evaluated at most [13,33].
Nevertheless, as a whole, WAD outperforms the others.
We also observed this trend for the 825 Gene Ontology
gene sets (file name “c5.bp.v3.0.symbols.gmt”) and for all
3,272 curated gene sets (“c2.all.v3.0.symbols.gmt”),
obtained from MSigDB ver. 3.0 [24] (data not shown). The
raw data for Figure 3 are available in Additional file 18.
Discussion
We investigated suitable gene ranking methods across var-
ious microarray platforms using a large set of MAQC
microarray data. In accordance with previous evaluation
frameworks [8,14], sensitivity and specificity of the meth-
ods were evaluated using an AUC metric where genes
were determined to be DEGs or non-DEGs based on RT-
PCR data. Reproducibility was evaluated using a POG
metric and Spearman’s correlation coefficient. The current
conclusions are essentially the same as those of our pre-
vious studies [8,14]: the best of the eight methods investi-
gated was (i) either WAD, RP, or ibmT, when both
sensitivity and specificity were evaluated and (ii) WAD
when reproducibility was evaluated. As we proposed one of
the methods (WAD) that is compared here, this study
could be regarded as the third in a series of studies on
WAD. In the first study [8], the high sensitivity and specifi-
city of the above-mentioned methods (especially WAD)
were demonstrated using two spike-in datasets [34,35] and
36 real experimental datasets. In the second study [14], the
sensitivity and specificity of the eight gene ranking meth-
ods coupled with nine pre-processing algorithms dedicated
to the Affymetrix (AFX) GeneChip data were further evalu-
ated using the 36 real experimental datasets, and high
reproducibility of WAD was demonstrated using the
MAQC data. However, our previous studies were based
only on datasets measured using the AFX platform. We
have demonstrated in this study that those recommenda-
tions are also applicable for the other four microarray
platforms.
Sensitivity and specificity
The current results indicate that care should be taken
when choosing both a gene ranking method for analyzing
microarray data and a metric for analyzing RT-PCR data.
In addition, there are more effective combinations of
the two choices: the WAD method in conjunction with
the FDR metric (WAD/FDR), RP/AD, and ibmT/FDR.
These combinations are logical because RP/AD are
both fold-change-based statistics and ibmT/FDR are both
t-statistic-based ones. Although WAD is a fold-change-
based method, the overall performance of WAD/FDR is
superior to that of ibmT/FDR (Table 3). To our knowledge,
no study has reported suitable combinations of the two
choices to facilitate agreement between the results. How-
ever, note that excessive value may have been placed on
the RT-PCR data when determining these combinations.
Although the RT-PCR technology is generally considered
the “gold-standard” assay for measuring gene expression by
biologists [36], it has not been proven as the best. In this
regard, our proposed combinations may be useful for dis-
cussion on the agreement or disagreement between the
results obtained by the two technologies.
Reproducibility
As mentioned, our previous study reports that WAD out-
performs the other methods when inter-site reproducibil-
ity is evaluated for AFX microarray data [14]. In the
current study, we demonstrate that WAD has clearly
higher inter-site reproducibility when DEG lists produced
from different test sites are compared, irrespective of the
choice of microarray platform (Table 4 and Additional
files 11, 12).
Li et al. recently reported high inter-platform reproduci-
bility at the biological function level obtained by using a
commercially available tool [13]. Only the samT method
[1] was used in their functional analysis, without any justi-
fication, despite citation of the original MAQC paper
where AD was recommended [18]. In addition, there
should be “levels” of reproducibility; the use of better gene
ranking methods should increase the level of inter-plat-
form reproducibility at the biological function level. How-
ever, comparison of many gene ranking methods at the
biological function level using such specialized tools is dif-
ficult practically for the following reasons: (1) gene ranking
methods of interest may not be used, (2) only a set of sig-
nificant gene sets can be manipulated, and so on. In parti-
cular, related to reason (1), to our knowledge there is no
method that can also analyze gene set enrichment in con-
junction with non-parametric gene ranking methods such
as RP [4]. In this sense, our simple non-parametric
approach to estimating gene set enrichment can be
deemed a new method. Our functional analysis using this
simple approach demonstrates that WAD has both high
intra- and inter-platform reproducibility at the biological
function level (Figures 2 and 3). We observed similarity
between the top-rank lists produced by this simple proce-
dure and those by two widely used methods (i.e., GSEA
[24] and PAGE [25]) when some real experimental data-
sets used in Refs. [24,25,37] were applied (data not
shown), but such a comparison is out of the scope of this
study. Improving the approach of using WAD for func-
tional analysis is future work.
In this study, we could perform a more detailed analysis
with regard to reproducibility by using MAQC datasets.
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However, the original MAQC study [18] has often been
criticized for its evaluation framework, where the correla-
tion coefficient and the POG were used as measures for
reproducible ranked gene lists [27-29]. Chen et al. [29] sta-
ted that the POG metric does not reflect the accuracy (i.e.,
sensitivity and specificity) of a ranked gene list. This is
true in a sense because, for example, POG values higher
than those of WAD can easily be obtained if we rank
genes according to relative average signal intensity (i.e., a
weight term (w ) in a WAD statistic; see Figure one in Ref.
[14]). This w statistic is clearly inferior to that obtained
from the other specialized gene ranking methods such as
WAD when the AUC value (both sensitivity and specifi-
city) is evaluated [8,14]. Evaluation based only on the
reproducibility of ranked gene lists is therefore insufficient.
In the current study, however, we compare the eight gene
ranking methods using the AUC value (both sensitivity
and specificity) as well as the POG value (reproducibility).
In addition, the most reproducible method (i.e., WAD) is
one of the three methods that found to have high sensitiv-
ity and specificity.
Other pre-processing methods
In this study, we analyzed publicly available datasets that
were already pre-processed according to the MAQC philo-
sophy [18]. Our additional processing for the datasets was
basically only the log2 transformation (see Materials and
Methods). As demonstrated by our previous study [14]
and another study of the MAQC project [38], there are
many other choices for pre-processing data (for example,
see Refs. [39-42]) and different choices may result in dif-
ferent conclusions. Thus, the other pre-processing choices
should be evaluated next.
Conclusion
In conclusion, the superiority of WAD was confirmed
with regard to sensitivity, specificity, and reproducibility
by using the MAQC datasets. We thus recommend the
use of WAD for more effective transcriptome analysis.
Additional material
Additional file 1: R-code for pre-processing GEH data. Input file must
be obtained from http://edkb.fda.gov/MAQC/MainStudy/upload/
norm_MAQC_GEH_123_Median1.zip. After execution of this R-code,
expression data consisting of 53,517 unique probes can be obtained as
an output file arbitrarily named
“norm_MAQC_GEH_123_Median1_unique.txt”. Note that the website
with the normalized MAQC data was unavailable under review. The raw
data may be availabl from. http://www.fda.gov/ScienceResearch/
BioinformaticsTools/Arraytrack/ or http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE5350.
Additional file 2: R-code for analyzing TAQ data. Two input files must
first be obtained from the following websites: “http://www.nature.com/
nbt/journal/v24/n9/extref/nbt1239-S5.txt“ and “http://edkb.fda.gov/MAQC/
MainStudy/upload/norm_TAQ_1_POLR2A.zip“. After execution of this R-
code, FDR and AD statistics for each comparison (i.e., “Sample A versus
B” and “C versus D”) can be obtained in an output file arbitrarily named
“data_TAQ.txt”. Note that the website with the normalized MAQC data
was unavailable under review. The raw data may be available from
http://www.fda.gov/ScienceResearch/BioinformaticsTools/Arraytrack/ or
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE5350.
Additional file 3: R-code for analyzing GEX data. Two input files must
first be obtained from the following websites: “http://www.nature.com/
nbt/journal/v24/n9/extref/nbt1239-S5.txt“ and “http://edkb.fda.gov/MAQC/
MainStudy/upload/norm_MAQC_GEX_1_ACTB.zip“. After execution of this
R-code, FDR and AD statistics for each comparison (i.e., “Sample A versus
B” and “C versus D”) can be obtained in an output file arbitrarily named
“data_GEX.txt”. Note that the website with the normalized MAQC data
was unavailable under review. The raw data may be available from
http://www.fda.gov/ScienceResearch/BioinformaticsTools/Arraytrack/ or
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE5350.
Additional file 4: R-code for calculating average AUC values for AFX
data across six test sites shown in Table 1. Two input files are
required. One is the AFX gene expression data file obtained from http://
edkb.fda.gov/MAQC/MainStudy/upload/
norm_MAQC_AFX_123456_qPLIER16.zip. The other includes the DEG
information derived from individual RT-PCR data. Specifically, the
filename should be “data_TAQ.txt” (default) or “data_GEX.txt”, generated
by executing Additional file 2 or 3, respectively. After execution of this R-
code, the average AUC values shown in Table 1 can be obtained in an
output file arbitrarily named “result_AFX.txt”. Note that the website with
the normalized MAQC data was unavailable under review. The raw data
may be available from http://www.fda.gov/ScienceResearch/
BioinformaticsTools/Arraytrack/ or http://www.ncbi.nlm.nih.gov/geo/
query/acc.cgi?acc=GSE5350.
Additional file 5: R-code for calculating average AUC values for ABI
data across three test sites shown in Table 2. Two input files are
required. One is the ABI gene expression data file obtained from http://
edkb.fda.gov/MAQC/MainStudy/upload/norm_MAQC_ABI_123_qNorm.zip.
The other includes the DEG information derived from individual RT-PCR
data. Specifically, the filename should be “data_TAQ.txt” (default) or
“data_GEX.txt”, generated by executing Additional file 2 or 3, respectively.
After execution of this R-code, the average AUC values for ABI data
shown in Table 2 can be obtained in an output file arbitrarily named
“result_ABI.txt”. Note that the website with the normalized MAQC data
was unavailable under review. The raw data may be available from
http://www.fda.gov/ScienceResearch/BioinformaticsTools/Arraytrack/ or
http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE5350.
Additional file 6: R-code for calculating average AUC values for AG1
data across three test sites shown in Table 2. Two input files are
required. One is the AG1 gene expression data file obtained from http://
edkb.fda.gov/MAQC/MainStudy/upload/
norm_MAQC_AG1_123_Median1GeneSpring.zip. The other includes the
DEG information derived from individual RT-PCR data. Specifically, the
filename should be “data_TAQ.txt” (default) or “data_GEX.txt”, generated
by executing Additional file 2 or 3, respectively. After execution of this R-
code, the average AUC values for AG1 data shown in Table 2 can be
obtained in an output file arbitrarily named “result_AG1.txt”. Note that
the website with the normalized MAQC data was unavailable under
review. The raw data may be available from http://www.fda.gov/
ScienceResearch/BioinformaticsTools/Arraytrack/ or http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc=GSE5350.
Additional file 7: R-code for calculating average AUC values for GEH
data across three test sites shown in Table 2. Two input files are
required. One is the GEH gene expression data file obtained by
executing Additional file 1, and the output file should be named
“norm_MAQC_GEH_123_Median1_unique.txt”. The other includes the
DEGs information derived from individual RT-PCR data. Specifically, the
filename should be “data_TAQ.txt” (default) or “data_GEX.txt”, generated
by executing Additional file 2 or 3, respectively. After execution of this R-
code, the average AUC values for GEH data shown in Table 2 can be
obtained in an output file arbitrarily named “result_GEH.txt”.
Additional file 8: R-code for calculating average AUC values for ILM
data across three test sites shown in Table 2. Two input files are required.
One is the ILM gene expression data file obtained from http://edkb.fda.gov/
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MAQC/MainStudy/upload/norm_MAQC_ILM_123_qNorm16.zip. The other
includes the information about DEGs derived from individual RT-PCR data.
Specifically, the filename should be “data_TAQ.txt” (default) or “data_GEX.txt”,
generated by executing Additional file 2 or 3, respectively. After execution of
this R-code, the average AUC values for ILM data shown in Table 2 can be
obtained in an output file arbitrarily named “result_ILM.txt”. Note that the
website with the normalized MAQC data was unavailable under review. The
raw data may be available from http://www.fda.gov/ScienceResearch/
BioinformaticsTools/Arraytrack/ or http://www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE5350.
Additional file 9: Average AUC values for all methods regarding
Table 3. Table 3 was obtained based on these values.
Additional file 10: R-code for obtaining average AUC values for AFX
data across six test sites when top X genes are defined as DEGs.
Two input files are required. One is the AFX gene expression data file
obtained from http://edkb.fda.gov/MAQC/MainStudy/upload/
norm_MAQC_AFX_123456_qPLIER16.zip. The other includes the DEG
information derived from individual RT-PCR data. Specifically, the
filename should be “data_TAQ.txt” (default) or “data_GEX.txt”, generated
by executing Additional file 2 or 3, respectively. After execution of this R-
code, a fraction of the average AUC values for the AFX data when top X
genes are defined as DEGs (X = 100 by default), shown in Additional file
9, can be obtained in an output file arbitrarily named “result_AFX_100.
txt”. Note that the website with the normalized MAQC data was
unavailable under review. The raw data may be available from http://
www.fda.gov/ScienceResearch/BioinformaticsTools/Arraytrack/ or http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE5350.
Additional file 11: POG values for given numbers of top-ranked
genes among three test sites. (a) AFX data, (b) ABI data, (c) AG1 data,
(d) GEH data, and (e) ILM data. Number of DEGs (X ) is shown on x -axis
(log-scale). Percentage of genes (POG) for X top-ranked genes among
three test sites is shown on y -axis.
Additional file 12: Raw data for Additional file 11. There are a total of
ten sheets (five platforms × two comparisons).
Additional file 13: Correlation coefficients of ranked gene lists
between any two test sites.
Additional file 14: Correlation coefficients of 186 ranked lists of
gene sets between any two test sites.
Additional file 15: Raw data for Figure 2. There are a total of ten
sheets (five platforms × two comparisons).
Additional file 16: R-code for making left side of Figure 2(a). The R-
code assumes the input filename is “POG_AFX_KEGG_AB.txt,” which
contains data for the first sheet (i.e., the sheet named “AFX_AvsB”) in
Additional file 15.
Additional file 17: Numbers of genes belonging to each of 186
KEGG Pathway gene sets in individual platforms.
Additional file 18: Raw data for Figure 3. There are two sheets.
List of abbreviations used
ABI: Applied Biosystems; AD: average difference; AFX: Affymetrix; AG1:
Agilent one-color microarray; AUC: area under the curve; FDR: false discovery
rate; GEH: GE Healthcare; GEX: StaRT-PCR; ibmT: intensity-based moderated t-
statistic; ILM: Illumina; MAQC: MicroArray Quality Control (project); POG:
percentage of overlapping genes; RP: rank products; samT: significance
analysis of microarrays; shrT: shrinkage t-statistic; TAQ: TaqMan; WAD:
weighted average difference (method)
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